Groups, the media, agency waiting costs, and FDA drug approval

American Journal of Political Science

Volumn 46, Issue 3, 2002, Pages 490-505

  Carpenter, Daniel P ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036323966     PISSN: 00925853     EISSN: None     Source Type: Journal    
DOI: 10.2307/3088394     Document Type: Article

References (44)

1. Time is of the essence: Event history models in political science
2. The political economy of the pharmaceutical industry
3. Do important drugs reach the market sooner?
4. Understanding the challenger disaster: Organizational structure and the design of reliable systems
5. Job matching and the theory of turnover
6. Optimal stopping of an integral of a Wiener process
7. Control and feedback in economic regulation: The case of the NLRB
8. Firm characteristics and the speed of FDA approval
9. Hierarchy and ecological control in federal budgetary decision making
10. An evaluation of consumer protection legislation: The 1962 drug amendments
11. The food and drug administration
12. Who works with whom? interest group alliances and opposition
13. Street level political controls over federal bureaucracy
14. Managing delegation ex ante: Using law to steer administrative agencies
15. AIDS and the politics of drug lag
16. When consumers oppose consumer protection: The politics of regulatory backlash
17. Principals, bureaucrats, and responsiveness in clean air enforcement
18. The dynamics of political control of the bureaucracy